- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-5076
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Immune checkpoint blockade in ovarian cancer ; day:2 ; month:6 ; year:2016 ; pages:1-3
Magazine of European Medical Oncology ; (2.6.2016), 1-3
- Urheber
-
Weiss, Lukas
- Beteiligte Personen und Organisationen
-
Huemer, Florian
Mlineritsch, Brigitte
Greil, Richard
SpringerLink (Online service)
- DOI
-
10.1007/s12254-016-0267-3
- URN
-
urn:nbn:de:1111-2016060329676
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Weiss, Lukas
- Huemer, Florian
- Mlineritsch, Brigitte
- Greil, Richard
- SpringerLink (Online service)
Ähnliche Objekte (12)
Immune Checkpoint Blockers and Ovarian Cancer
Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade
Microbial biomarkers for immune checkpoint blockade therapy against cancer
Immune Checkpoint Blockade: The New Frontier in Cancer Treatment
Correction to: Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade
Smoldering myocarditis following immune checkpoint blockade
Targeting branched N-glycans and fucosylation sensitizes ovarian tumors to immune checkpoint blockade
Perspective: cancer vaccines in the era of immune checkpoint blockade
Immunology and Immune Checkpoint Inhibition in Ovarian Cancer – Current Aspects
Activation of phagocytosis by immune checkpoint blockade
Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer
Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment
Immune Checkpoint Blockers and Ovarian Cancer
Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade
Microbial biomarkers for immune checkpoint blockade therapy against cancer
Immune Checkpoint Blockade: The New Frontier in Cancer Treatment
Correction to: Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade
Smoldering myocarditis following immune checkpoint blockade
Targeting branched N-glycans and fucosylation sensitizes ovarian tumors to immune checkpoint blockade
Perspective: cancer vaccines in the era of immune checkpoint blockade
Immunology and Immune Checkpoint Inhibition in Ovarian Cancer – Current Aspects
Activation of phagocytosis by immune checkpoint blockade
Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer
Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment
Immune Checkpoint Blockers and Ovarian Cancer
Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade
Microbial biomarkers for immune checkpoint blockade therapy against cancer
Immune Checkpoint Blockade: The New Frontier in Cancer Treatment
Correction to: Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade
Smoldering myocarditis following immune checkpoint blockade
Targeting branched N-glycans and fucosylation sensitizes ovarian tumors to immune checkpoint blockade
Perspective: cancer vaccines in the era of immune checkpoint blockade
Immunology and Immune Checkpoint Inhibition in Ovarian Cancer – Current Aspects
Activation of phagocytosis by immune checkpoint blockade
Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer